Tesamorelin side effects seen in human studies
The makers expected growth hormone and IGF-1, a growth protein, to rise. Trials watched shot sites, fluid, joints, blood sugar, the liver, and cancer risk.
The main tesamorelin side effects
Tesamorelin’s makers expected growth hormone already made in the body to rise, so trials watched for sore or red shot sites, joint pain, headache, fluid buildup, and higher IGF-1, a growth-related blood protein. Blood-sugar changes were too slight to change care over one year. A government review judged liver injury unlikely.
I kept one limit in mind for you: the studies can’t tell whether cancer becomes more likely after years of use. Fat near the organs also came back after the drug ended. Athletes face a sport ban. These facts show you both the known harms and the questions no study has answered.
What happened to people taking tesamorelin
Sore, red, or swollen shot sites were the most common trouble. Studies also found headache, sore joints, and fluid in the hands or feet. These effects can follow higher growth hormone and IGF-1, a growth protein [1][4]. During the 52-week study, no serious harm was tied to tesamorelin. The blood-sugar shift was too small to affect care during those 52 weeks [2].
A government liver review gave tesamorelin a score of E. In plain words, liver injury looked unlikely. Liver blood tests didn’t start climbing, and no trial case of liver injury was traced to tesamorelin [5].
That news can offer some comfort, but the studies watched people receiving HIV care for a limited time. They can’t tell us what happens to other people after many years.
How safe tesamorelin looked for one year
The longer trial brought fairly calm safety news. During the 52-week program, researchers tied no serious harm to tesamorelin. Blood-sugar changes stayed too slight to change care [2]. A government liver review gave the drug a score of E, meaning liver injury looked unlikely [5].
Still, “safe” needs a group and a length of time. These studies watched people receiving HIV care for no more than a year. Tesamorelin raises IGF-1, a growth protein, so they can’t settle cancer risk years later, and your health may raise questions those studies didn’t ask.
What tesamorelin did to blood sugar
A small study followed 13 healthy men. It found no clear shift in blood sugar after a fast or in how their bodies handled sugar after insulin [4]. A 52-week HIV study also saw blood sugar move too little to alter care [2].
Growth hormone can still push blood sugar upward. If your blood sugar is already hard to control, that gives a doctor reason to follow it with blood tests.
Why tesamorelin can cause fluid buildup
Growth hormone can make body tissues hold extra fluid. Tesamorelin raises that hormone and IGF-1, a growth-related blood protein, so swelling can follow [4]. People in the studies also reported sore joints, which can come with fluid buildup.
The 52-week trial tied no serious harm to tesamorelin [2]. Even so, that result can’t tell whether swelling in your hands, feet, or legs is safe for you.
What the IGF-1 blood test leaves unknown
Tesamorelin is meant to raise IGF-1, a growth-related protein made mostly by the liver [4]. No extra cancer warning appeared during 52 weeks of study [2]. That period can’t tell you whether cancer becomes more likely after years of use.
The label says: do not use tesamorelin while cancer is active [5]. The IGF-1 rise and the growth-hormone rise are tied to both the wanted fat change and the long-term doubt. Longer studies don’t yet exist.
What changed in blood tests tied to heart risk
As scans showed less deep fat, tissue plasminogen activator antigen fell; high levels of this blood protein can go with more trouble breaking down clots. Adiponectin comes from fat cells, and its level rose a little [11]. Doctors often link more adiponectin with better use of sugar and fat. Both changes were larger when more deep fat was lost. That points to fat loss as the cause, not a direct effect on blood vessels [11].
A common blood fat also fell 50 milligrams per deciliter in the main trial [1]. A deciliter holds one-tenth of a liter, which gives you a sense of the amount. These results don’t prove that tesamorelin prevents heart attacks or strokes. The studies didn’t test that question.
What happened after tesamorelin stopped
Deep belly fat began to build up again after people stopped tesamorelin [2]. The benefit depended on staying on the drug. That fact matters when you weigh the benefit against the harms.
Longer use also means more time with a drug that raises growth hormone and IGF-1. No study yet tells you whether cancer becomes more likely after years of use. The current record can’t tell you how that tradeoff turns out.
Who must avoid tesamorelin
Anyone whose cancer is active has to avoid tesamorelin. The reason is that growth hormone and IGF-1, a liver-made growth protein, rise with the drug. People whose blood sugar is hard to control may need blood tests [4][5]. The drug is banned in sport [15].
A lab-only product isn’t medicine a person can inject. A licensed clinician weighs your health history before deciding whether to prescribe tesamorelin, including a compounded preparation; treatment may be declined.